The private equity firm CapVest has acquired the German drugmaker Stada at about a €10bn valuation from its previous owners, marking one of Europe’s largest healthcare transactions this year.
Stada, which sells generic drugs and consumer health products, was delisted from the Frankfurt stock exchange in 2017 by the buyout investors Bain Capital and Cinven for €5.3bn.
The two firms had been exploring options for Stada including an initial public offering, and will retain a minority stake in the company following CapVest’s takeover, according to a statement on Monday.
您已閱讀28%（570字），剩余72%（1447字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。